Many U.S. Adults View Marijuana Use Positively
WEDNESDAY, July 25, 2018 -- Most U.S. adults believe that marijuana has at least one benefit, according to a study published online July 24 in the Annals of Internal Medicine. Salomeh Keyhani, M.D., M.P.H., from the University of California in San... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 25, 2018 Category: Pharmaceuticals Source Type: news

Guidelines for ART Updated for Those With or at Risk for HIV
WEDNESDAY, July 25, 2018 -- Recommendations for antiretroviral therapy (ART) have been updated for individuals at risk of or living with HIV; the 2018 recommendations of the International Antiviral Society-USA Panel are published in the July 24/31... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 25, 2018 Category: Pharmaceuticals Source Type: news

Scientist Invented A New Pathway To Approve Biosimilars, And The FDA Is Listening
In an extraordinary move, the FDA has withdrawn draft guidance for biosimilars after receiving public comments and 1 citizen petition. But what makes the FDA about-face on biosimilar evaluation so monumental is that it was the direct result of the citizen petition. Filed by one man: Sarfaraz Niazi. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 25, 2018 Category: Pharmaceuticals Authors: Nicole Fisher, Contributor Source Type: news

AbbVie-Backed Startup Raises $133 Million To Fight Alzheimer's With Immunotherapy
With backing from some of biotech's biggest players, Alector, a startup taking on Alzheimer's disease announced Wednesday that it has raised $133 million in a Series E funding round. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 25, 2018 Category: Pharmaceuticals Authors: Michela Tindera, Forbes Staff Source Type: news

GSK invests $300m in gene profiling group 23andMe
Equity stake in Google Ventures-backed group comes as drugmaker unveils ‘major restructuring’ (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - July 25, 2018 Category: Pharmaceuticals Source Type: news

23andMe Gets $300 Million Boost From GlaxoSmithKline To Develop New Drugs
GlaxoSmithKline, a London-based drug giant is partnering with 23andMe, the San Francisco genetics startup, to develop new medicines. The companies will split costs and profits equally, and Glaxo will make a $300 million investment in 23andMe. The collaboration will last four years. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 25, 2018 Category: Pharmaceuticals Authors: Matthew Herper, Forbes Staff Tags: NYSE:GSK NASDAQ:DNLI Source Type: news

Women and older people under-represented in drug trials for heart disease
Trying to determine how best to treat a patient, doctors often look to randomized clinical trials to guide their choice of what drug to prescribe. One of the most common illnesses is heart disease, and in recent years it's been proven that, contrary to popular belief, more women have heart problems than men do; similarly, it's more common for older people to have a heart condition than younger people. But do clinical trials reflect this reality? (Source: World Pharma News)
Source: World Pharma News - July 25, 2018 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

How Do Sugar, Coffee, Alcohol And More Foods Really Impact Health? A New Report Tests The Evidence
A new research review tests health claims made for several popular foods, revealing the good, bad and indifferent evidence to help make informed dietary decisions. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 25, 2018 Category: Pharmaceuticals Authors: David DiSalvo, Contributor Source Type: news

Can We Trust The Health Claims For Hyped Foods? A New Research Review Tests The Evidence
A new research review tests health claims made for several popular foods, revealing the good, bad and indifferent evidence to help make informed dietary decisions. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 25, 2018 Category: Pharmaceuticals Authors: David DiSalvo, Contributor Source Type: news

My First Million — Zef Eisenberg, founder of Maximuscle
I crashed at 230mph, had three months in hospital and was back racing a year later (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - July 25, 2018 Category: Pharmaceuticals Source Type: news

Bayer to no longer sell permanent birth control implant Essure
The pharma company said the decision was based on poor sales, not health risks. (Source: ABC News: Health)
Source: ABC News: Health - July 25, 2018 Category: Consumer Health News Tags: GMA Source Type: news

How Oregon Works: Health care training and resource guide
MEDICAL SCHOOL PORTLAND  OHSU School of Medicine ohsu.edu 503-494-8220 NURSING PROGRAMS ASHLAND  OHSU at Southern Oregon University sou.edu  541-552-8453 ASTORIA  Clatsop Community College  clatsopcc.edu  503-338-2436  BEAVERTON Pioneer Pacific College pioneerpacific.edu 503-688-2130  BE ND  Central Oregon Community College cocc.edu  541-383-7546  COOS BAY  Southwestern Oregon Community College  socc.edu  541-888-7298  EUGENE  Lane Community College  lanecc.edu 541-463-5730  GRANTS… (Source: bizjo...
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 25, 2018 Category: Pharmaceuticals Source Type: news

Study Finds Reducing BMI Could Achieve $461 Million in Economic...
Body mass index (BMI) reductions among a sample group of 12,561 Isagenix International customers could save the U.S. economy $461 million over 20 years due to avoided medical treatment costs and...(PRWeb July 25, 2018)Read the full story at https://www.prweb.com/releases/study_finds_reducing_bmi_could_achieve_461_million_in_economic_benefit_over_20_years_for_sample_group_of_isagenix_customers/prweb15652897.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - July 25, 2018 Category: Pharmaceuticals Source Type: news

Vium Enhances Roster of Senior Leaders With Key Hires And Strategic...
Additions and advancements further strengthens Vium’s position to improve in vivo data insights for the world's top pharma and biotech companies.(PRWeb July 25, 2018)Read the full story at https://www.prweb.com/releases/vium_enhances_roster_of_senior_leaders_with_key_hires_and_strategic_promotion_of_chief_scientific_officer/prweb15642716.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - July 25, 2018 Category: Pharmaceuticals Source Type: news

Annual Expedition Mt. Kinabalu Raises Awareness of a Duchenne Clinical...
Enrollment for Duchenne Muscular Dystrophy Clinical Trial Now Underway(PRWeb July 25, 2018)Read the full story at https://www.prweb.com/releases/annual_expedition_mt_kinabalu_raises_awareness_of_a_duchenne_clinical_trial_bringing_treatments_to_boys_in_malaysia/prweb15650024.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - July 25, 2018 Category: Pharmaceuticals Source Type: news

Packline Materials Handling Announce The New Roll Handling Equipment...
New to Packline, the roll lifting equipment with powered drive has been designed to meet criteria where the minimum amount of physical effort is required to provide precision manoeuvrability of the...(PRWeb July 25, 2018)Read the full story at https://www.prweb.com/releases/2018/06/prweb15563177.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - July 25, 2018 Category: Pharmaceuticals Source Type: news

Stanford, Harvard geneticists launch biotech to fight deadly bacteria
Professors at Harvard University and Stanford University have joined forces to launch a biotech startup that is developing a fluid-testing tool and disease database — an ambitious project that could one day cut laboratory testing time down to an hour and help stop deadly outbreaks.  "We're working toward a one-stop solution for infection," Harvard geneticist Dr. David Andrew Sinclair said of Arc Bio, which emerged from stealth Tuesday. "Eventually, we'll be the place that researchers and hospitals… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 24, 2018 Category: Pharmaceuticals Authors: Allison DeAngelis Source Type: news

Citing Trump policies, movement builds to shift important AIDS meeting from Bay Area
A call to move a biennial international AIDS conference from the Bay Area because of Trump administration policies, including restrictions on potential attendees and the impact of those policies on attempts to halt the spread of HIV globally, is splitting the AIDS community. When organizers of the International AIDS Conference said in March that the meeting was returning for the first time in 30 years to San Francisco and Oakland in 2020, they hailed it as a defining moment in the battle against… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 24, 2018 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

Emory Johns Creek Hospital plans $61 million expansion
Emory Johns Creek Hospital is planning to build two new stories on its facility. The expansion will add 84,000 square feet, 21 inpatient acute care beds, 19 observation beds, an inpatient dialysis room and meeting and conference spaces, according to the letter of intent the hospital filed with the state on Tuesday. The estimated cost for the project is $61 million. EJCH fir st opened in 2007. During the Johns Creek state of the city address in March 2018, the hospital administrators reported… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 24, 2018 Category: Pharmaceuticals Authors: Mollie Simon Source Type: news

U.S. media decries China's censorship of a massive vaccine scandal, even while the U.S. media censors all the vaccine scandals covered up by the CDC
(Natural News) A vaccine scandal has broken out in China: Regulators say that multiple problems, including falsified records, were found at a large pharma company which produces a rabies vaccine. In the aftermath, Chinese censors were tasked with deleting articles and removing any and all postings about the scandal, erasing virtually any trace of public... (Source: NaturalNews.com)
Source: NaturalNews.com - July 24, 2018 Category: Consumer Health News Source Type: news

Amgen Announces Webcast of 2018 Second Quarter Financial Results
THOUSAND OAKS, Calif., July 24, 2018 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its second quarter 2018 financial results on Thursday, July 26, 2018, after the close of the U.S. financial markets. The announcement will be followed by a conference call with the investment community at 2:00 p.m. PT. Participating in the call from Amgen will be Robert A. Bradway, chairman and chief executive officer, and other members of Amgen's senior management team. Live audio of the conference call will be simultaneously broadcast over the internet and will be available to members of the news media, investo...
Source: Amgen News Release - July 24, 2018 Category: Pharmaceuticals Tags: Uncategorized Source Type: news

Eisai, Biogen move forward with Alzheimer's med after initial failure
The two drugmakers'treatment was found to slow Alzheimer ’s progression at its highest dose, allowing the partnership to move forward with late-stage clinical trials (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - July 24, 2018 Category: Pharmaceuticals Source Type: news

ICER ’s budget impact threshold: Sounding a false alarm on affordability and access
If a home inspector found “wide and unpredictable variation” in your smoke detectors, would you want to fix them? (Source: The Catalyst)
Source: The Catalyst - July 24, 2018 Category: Pharmaceuticals Authors: Randy Burkholder Tags: Access Value Value-Driven Health Care The Value Collaborative Source Type: news

GSK two-drug HIV combo finds success in key study
The experimental combo of dolutegravir and lamivudine was found to be just as effective as a standard triple HIV therapy (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - July 24, 2018 Category: Pharmaceuticals Source Type: news

Parents' Childhood Affects Their Children's Behavioral Health
TUESDAY, July 24, 2018 -- Parents'adverse childhood events (ACEs), such as abuse, neglect, or household dysfunction, can impact their children's lives, according to a study published online July 9 in Pediatrics. Adam Schickedanz, M.D., Ph.D., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 24, 2018 Category: Pharmaceuticals Source Type: news

Reduced Cognitive Function for Students During Heat Waves
TUESDAY, July 24, 2018 -- Cognitive function deficits resulting from indoor thermal conditions during heat waves affect university students, according to a study published online July 10 in PLOS Medicine. Jose Guillermo Cede ño Laurent, from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 24, 2018 Category: Pharmaceuticals Source Type: news

Physicians and Practices Should Prepare for Emergencies
TUESDAY, July 24, 2018 -- Practices and physicians should prepare for emergency situations, such as natural disasters, network communications failures, and active shooter situations, according to an article published in Medical Economics. Physicians... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 24, 2018 Category: Pharmaceuticals Source Type: news

Lowering Default Number of Pills Can Reduce Prescribed Opioids
TUESDAY, July 24, 2018 -- Reducing the default number of opioid pills prescribed in an electronic medical record (EMR) system can effectively decrease the amount of opioids prescribed after procedures, according to a study published online July 18... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 24, 2018 Category: Pharmaceuticals Source Type: news

11 Infant Deaths Halt Trial of Sildenafil in Pregnant Women
TUESDAY, July 24, 2018 -- There have been 11 lung-related infant deaths after pregnant women in the Netherlands were given sildenafil (Viagra) to boost the growth of their babies while in the womb. The clinical trial included women whose placentas... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 24, 2018 Category: Pharmaceuticals Source Type: news

First ischemic stroke patients treated with embotrap ii revascularization device since commercial availability in u.s.
(Source: Johnson and Johnson)
Source: Johnson and Johnson - July 24, 2018 Category: Pharmaceuticals Source Type: news

Allegro training programme – First rotation in agency life
It has been nearly 7 months since I joined the Allegro programme, an initiative launched by Ashfield Healthcare Communications to fast track the training of new Associate Medical... The post Allegro training programme – First rotation in agency life appeared first on Ashfield Healthcare. (Source: Ashfield Healthcare News)
Source: Ashfield Healthcare News - July 24, 2018 Category: Pharmaceuticals Authors: Ashfield Source Type: news

Allegro Training Programme – 1st Rotation in Agency Life
It has been nearly 7 months since I joined the Allegro programme, an initiative launched by Ashfield Healthcare Communications Group Ltd to fast track the training of new... The post Allegro Training Programme – 1st Rotation in Agency Life appeared first on Ashfield Healthcare. (Source: Ashfield Healthcare News)
Source: Ashfield Healthcare News - July 24, 2018 Category: Pharmaceuticals Authors: Georgia Woodhall Source Type: news

How Pharma Cons Medicare; Trans Woman's Rx Nixed;'Dr. Butt' Busted
(MedPage Today) -- The past week in healthcare investigations (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - July 24, 2018 Category: Primary Care Source Type: news

Glaxo ’s New Research Chief Loves Big Pharma. Now He Has To Fix It
GlaxoSmithKline is turning to a new chief scientific officer, Hal Barron, to reinvigorate its drug pipeline. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 24, 2018 Category: Pharmaceuticals Authors: Matthew Herper, Forbes Staff Source Type: news

Despite Houston's strong health care sector, developers could expect a pause
"Health care systems are tightening their belts." (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 24, 2018 Category: Pharmaceuticals Authors: Cara Smith Source Type: news

Going public, Provention Bio looks to tackle immune-mediated diseases
Shares in Oldwick, N.J.-based Provention Bio began trading today following the close of its $64 million initial public offering last week. The biopharmaceutical company, lead by co-founder & CEO Ashleigh Palmer, is developing a number of products that aim to prevent or stop the spread of immune-mediated diseases, including Lupus, Crohn’s disease and Type I diabetes. Provention Bio’s strategy is to find drugs that have been developed by other pharmaceutical companies and take them through the clinical development process. But Palmer draws a clear distinction – the company is not &ld...
Source: Mass Device - July 24, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Biotech Funding Roundup Initial Public Offering (IPO) Pharmaceuticals Wall Street Beat proventionbio Source Type: news

Janssen announces JULUCA ® (dolutegravir/rilpivirine) maintains viral suppression with two drugs in a once-daily, single-pill
(Source: Johnson and Johnson)
Source: Johnson and Johnson - July 24, 2018 Category: Pharmaceuticals Source Type: news

Houston medical device startup hires former Abbott exec as CEO
Houston-based Procyrion Inc., which is developing a catheter-deployed micropump to manage chronic heart failure, has hired a new president and CEO, effective immediately.   The board of directors selected Dr. Eric Fain to fill the roles and “accelerate the progression of product development leading to human clinical trials and commercialization” of the heart pump technology, called Aortix, according to a July 23 press release. Previous CEO Benjamin Hertzog rema in with Procyrion in a different… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 24, 2018 Category: Pharmaceuticals Authors: Olivia Pulsinelli Source Type: news

Despite Houston's strong health care sector, developers could expect a pause
"Health care systems are tightening their belts." (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 24, 2018 Category: Pharmaceuticals Authors: Cara Smith Source Type: news

Centene's Obamacare Profits Surge As Insurer Enters New Markets
Centene's second-quarter profits surged 18% thanks to improving sales and profits in the Obamacare business under the Affordable Care Act. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 24, 2018 Category: Pharmaceuticals Authors: Bruce Japsen, Contributor Tags: NYSE:UNH NYSE:CNC NYSE:ANTM NYSE:AET Source Type: news

Janssen Presents Switch Data for New HIV-1 Treatment SYMTUZA ™ (D/C/F/TAF) and Second Study Supporting its Use in a Rapid Initiation Scenario
(Source: Johnson and Johnson)
Source: Johnson and Johnson - July 24, 2018 Category: Pharmaceuticals Source Type: news

Abbott Introduces Breakthrough Point-of-Care Test, the m-PIMA ™ HIV-1/2 Viral Load (VL), at AIDS 2018 Amsterdam
NEW POINT-OF-CARE DIAGNOSTIC SOLUTION AIMS TO MAKE EFFECTIVE CARE MORE ACCESSIBLE FOR MILLIONS OF HIV PATIENTS, CONSISTENT WITH UNAIDS ’ 90-90-90 GOALS (Source: Abbott.com)
Source: Abbott.com - July 24, 2018 Category: Pharmaceuticals Source Type: news

Durham company to sell program it bought from Pfizer
Durham-based Bioventus has inked an agreement to divest a spine fusion-focused development program it acquired from pharmaceutical giant Pfizer (NYSE: PFE) back in 2013. New York-based private equity firm Viscogliosi Brothers (VB) has agreed to acquire the bone morphogenetic protein (BMP) portfolio from Bioventus for an undisclosed price and form a new company to continue to advance the program. The deal – expected to close late in the third quarter – will see Bioventus take an equity stake… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 24, 2018 Category: Pharmaceuticals Authors: Jennifer Henderson Source Type: news

Murfreesboro health firm lands $4.3 million investment
Another year equals another big investment for Murfreesboro-based TwelveStone Health Partners from Claritas Capitol. TwelveStone, which provides chronic-care medication services, announced Tuesday that Nashville-based Claritas has invested $4.3 million to fuel the company’s expansion, according to a news release. Terms were not disclosed. The private equity firm invested $3.3 million into TwelveStone last year . “This is a significant vote of confidence in our team,” Shane Reeves, TwelveStone’s… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 24, 2018 Category: Pharmaceuticals Authors: Joel Stinnett Source Type: news

When Sharks Attack Lung Disease, And More Science You Won't Learn On'Shark Week '
While the Discovery Channel frightens viewers during the 30th year of Shark Week, scientists are embracing the creatures for their potential to inspire life-saving therapies. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 24, 2018 Category: Pharmaceuticals Authors: Arlene Weintraub, Contributor Source Type: news

OP-based KanCare contractor files lawsuit against state
Amerigroup Kansas Inc., which is based out of offices in Overland Park, is taking legal action against the state of Kansas in conjunction with how three KanCare contracts were recently awarded. The subsidiary of Virginia-based Amerigroup Corp., which is itself a part of Anthem Inc. (NYSE: ANTM), filed a lawsuit Friday asking for a review of the state's request for proposals process. Last month, Sunflower State Health Plan Inc., United Healthcare Midwest Inc. and Aetna Better Health of Ka nsas Inc.… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 24, 2018 Category: Pharmaceuticals Authors: Josh Heck Source Type: news

Brentwood firm to hire up to 500 people
NaviHealth CEO Clay Richards has a simple explanation for why 55 percent of the company was sold to a private-equity firm last month — it’s time to grow. Richards said Brentwood-based NaviHealth expects to enter 20 new markets over the next 12 months and add 400 to 500 employees over the next 18 months. The company currently employees about 1,000 people total, with 425 based in the Nashville area, he said. Publicly traded C ardinal Health Inc. (NYSE: CAH) sold a 55 percent stake in NaviHealth… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 24, 2018 Category: Pharmaceuticals Authors: Joel Stinnett Source Type: news

Nitrogen Dioxide Doesn't Impact Benefit of Exercise on MI
TUESDAY, July 24, 2018 -- Nitrogen dioxide does not affect the benefits of physical activity on the incidence or recurrence of myocardial infarction (MI), according to a study published online July 18 in the Journal of the American Heart... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 24, 2018 Category: Pharmaceuticals Source Type: news

Child Health Concerns Related to Use of Food Additives
TUESDAY, July 24, 2018 -- Regulatory changes are needed to address child health concerns related to the use of food additives, according to a policy statement published online July 23 in Pediatrics. Leonardo Trasande, M.D., M.P.P., from New York... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 24, 2018 Category: Pharmaceuticals Source Type: news

HPV Vaccine Eliminates Advanced Skin Cancer in 97-Year-Old
TUESDAY, July 24, 2018 -- The 9-valent human papillomavirus (HPV) vaccine could be a therapeutic option for patients with cutaneous squamous cell carcinoma when surgical management is not an option, according to a case report published online July 3... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 24, 2018 Category: Pharmaceuticals Source Type: news